Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029126089> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3029126089 endingPage "3" @default.
- W3029126089 startingPage "1" @default.
- W3029126089 abstract "Objective To evaluate the prognostic value of pro-atrial natriuretic peptide (pro-ANP) and pro-adrenomedullin (pro-ADM) levels in a cohort of medical intensive care patients, comparing them with other biomarkers and physiological score. Methods We performed prospective trial, according to the international criteria, 51 critically ill patients admitted to the intensive care unit were classified into four groups: systemic inflammatory response syndrome (SIRS) (n=25), sepsis (n=12), severe sepsis (n=9) and septic shock (n=5). The levels of plasma pro-ANP and pro-ADM were measured in each group, and compared with the other biomarkers(i. e. procalcitonin, C-reactive protein and IL-6) and the acute physiology and chronic health evaluation(APACHE)Ⅱ score. Pro- ANP and pro- ADM were detected using a new sandwich iminunoassay. Results On admission, median pro - ANP pro - ADM levels on admission (μg/L) were 87.22 (32.60) and 0.34(0.21) in patients with systemic inflammatory response syndrome, 533.30(119.47) and 2.23 (0.86) in those with sepsis, 1098.73 (236.63) and 4.57 (2.01) in those with severe sepsis, 1933.94 (417.31) and 8.21 (3.27) in patients with septic shock. With the increasing severity of the disease, the levels of pro - ANP, pro - ADM gradually increased. On admission, circulating pro-ANP and pro-ADM levels in patients with sepsis, severe sepsis, or septic shock were significantly highei in nonsurvivors than in survivors(P<0.05) . In a receiver operating curve analysis of survival of patients with sepsis, the area under the curve (AUC) for pro - ANP, pro - ADM were 0.89 and 0.87, which was similar to the AUCs for PCT(0.81), acute physiology and chronic health evaluation Ⅱ score (0.81). Conclusions Pro-ANP and pro-ADM is a valuable tool for prognostic and individual risk stratification of sepsis patients.Key words: Pro-atrial natriuretic peptide; Pro-adrenomedullin; Sepsis; Prognosis" @default.
- W3029126089 created "2020-06-05" @default.
- W3029126089 creator A5083583659 @default.
- W3029126089 date "2009-09-25" @default.
- W3029126089 modified "2023-09-24" @default.
- W3029126089 title "Clinical value of pro-atrial natriuretic peptide and pro-adrenomedullin to predict severity and outcome in sepsis" @default.
- W3029126089 doi "https://doi.org/10.3760/cma.j.issn.1674-4756.2009.18.001" @default.
- W3029126089 hasPublicationYear "2009" @default.
- W3029126089 type Work @default.
- W3029126089 sameAs 3029126089 @default.
- W3029126089 citedByCount "0" @default.
- W3029126089 crossrefType "journal-article" @default.
- W3029126089 hasAuthorship W3029126089A5083583659 @default.
- W3029126089 hasConcept C10936531 @default.
- W3029126089 hasConcept C126322002 @default.
- W3029126089 hasConcept C164705383 @default.
- W3029126089 hasConcept C170493617 @default.
- W3029126089 hasConcept C188816634 @default.
- W3029126089 hasConcept C2775915353 @default.
- W3029126089 hasConcept C2776376669 @default.
- W3029126089 hasConcept C2777152744 @default.
- W3029126089 hasConcept C2777628635 @default.
- W3029126089 hasConcept C2778069365 @default.
- W3029126089 hasConcept C2778198053 @default.
- W3029126089 hasConcept C2778384902 @default.
- W3029126089 hasConcept C2781090800 @default.
- W3029126089 hasConcept C2781300812 @default.
- W3029126089 hasConcept C71924100 @default.
- W3029126089 hasConcept C90924648 @default.
- W3029126089 hasConceptScore W3029126089C10936531 @default.
- W3029126089 hasConceptScore W3029126089C126322002 @default.
- W3029126089 hasConceptScore W3029126089C164705383 @default.
- W3029126089 hasConceptScore W3029126089C170493617 @default.
- W3029126089 hasConceptScore W3029126089C188816634 @default.
- W3029126089 hasConceptScore W3029126089C2775915353 @default.
- W3029126089 hasConceptScore W3029126089C2776376669 @default.
- W3029126089 hasConceptScore W3029126089C2777152744 @default.
- W3029126089 hasConceptScore W3029126089C2777628635 @default.
- W3029126089 hasConceptScore W3029126089C2778069365 @default.
- W3029126089 hasConceptScore W3029126089C2778198053 @default.
- W3029126089 hasConceptScore W3029126089C2778384902 @default.
- W3029126089 hasConceptScore W3029126089C2781090800 @default.
- W3029126089 hasConceptScore W3029126089C2781300812 @default.
- W3029126089 hasConceptScore W3029126089C71924100 @default.
- W3029126089 hasConceptScore W3029126089C90924648 @default.
- W3029126089 hasIssue "18" @default.
- W3029126089 hasLocation W30291260891 @default.
- W3029126089 hasOpenAccess W3029126089 @default.
- W3029126089 hasPrimaryLocation W30291260891 @default.
- W3029126089 hasRelatedWork W1191042202 @default.
- W3029126089 hasRelatedWork W1987482411 @default.
- W3029126089 hasRelatedWork W1990053503 @default.
- W3029126089 hasRelatedWork W2030273169 @default.
- W3029126089 hasRelatedWork W2034900388 @default.
- W3029126089 hasRelatedWork W2086955793 @default.
- W3029126089 hasRelatedWork W2090380982 @default.
- W3029126089 hasRelatedWork W2131635698 @default.
- W3029126089 hasRelatedWork W2185604762 @default.
- W3029126089 hasRelatedWork W2313280417 @default.
- W3029126089 hasRelatedWork W2316360511 @default.
- W3029126089 hasRelatedWork W2321725245 @default.
- W3029126089 hasRelatedWork W2365680208 @default.
- W3029126089 hasRelatedWork W2378873084 @default.
- W3029126089 hasRelatedWork W2383762511 @default.
- W3029126089 hasRelatedWork W2605074594 @default.
- W3029126089 hasRelatedWork W2966327134 @default.
- W3029126089 hasRelatedWork W3013742356 @default.
- W3029126089 hasRelatedWork W3114939082 @default.
- W3029126089 hasRelatedWork W3163376687 @default.
- W3029126089 hasVolume "36" @default.
- W3029126089 isParatext "false" @default.
- W3029126089 isRetracted "false" @default.
- W3029126089 magId "3029126089" @default.
- W3029126089 workType "article" @default.